ESC Premium Access

Changing clinical outcomes with more intensive platelet inhibition

logo

Congress Presentation

About the speaker

Professor Christopher Paul Cannon

Brigham and Women's Hospital, Boston (United States of America)
38 presentations
0 follower

5 more presentations in this session

Welcome and Introduction

Speaker: Professor L. Wallentin (Uppsala, SE)

Thumbnail

Manipulating the platelet - Successes and failures

Speaker: Professor R. Storey (Sheffield, GB)

Thumbnail

Effects in various clinical settings, patient subsets and healthcare realities

Speaker: Professor S. James (Uppsala, SE)

Thumbnail

Intensive platelet inhibition - Have we reached the ceiling or are there options for further development?

Speaker: Professor L. Wallentin (Uppsala, SE) Professor R. Storey (Sheffield, GB) Professor C. Cannon (Boston, US) Professor S. James (Uppsala, SE) Professor R. Mehran (New York, US)

Thumbnail

Summary and close

Speaker: Professor R. Mehran (New York, US)

Thumbnail

Access the full session

Intensive platelet inhibition in acute coronary syndromes - Where are we a decade after PLATO study results? (EBAC Accredited)

Speakers: Professor C. Cannon, Professor L. Wallentin, Professor R. Storey, Professor S. James, Professor L. Wallentin...
Thumbnail

About the event

Image

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb